Alcohol Use in Patients with Chronic Liver Disease
@article{Fuster2018AlcoholUI, title={Alcohol Use in Patients with Chronic Liver Disease}, author={Daniel Fuster and Jeffrey H. Samet}, journal={The New England Journal of Medicine}, year={2018}, volume={379}, pages={1251–1261} }
Alcohol Use in Patients with Chronic Liver Disease Alcohol use is common in patients with liver disease, but medications effective in alcohol-use disorder are used sparingly. Even patients with adv...
81 Citations
Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis
- Medicine, PsychologyHepatology
- 2019
This work characterized the use of and outcomes associated with AUD treatment in patients with cirrhosis and their impact on clinical outcomes in this population.
The effects of binge drinking on healthy and diseased livers
- Medicine
- 2021
The estimated global prevalence of alcohol abuse is 5%–15%, with 15%–20% of these individuals being considered binge drinkers. Despite the high prevalence, the effects of binge drinking on healthy ...
Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use
- MedicineWorld journal of gastroenterology
- 2021
Current knowledge around the use of non-invasive methods to assess liver disease, such as abdominal ultrasound, controlled attenuation parameter, transient elastography, magnetic resonance imaging, and indices based on serum markers of liver injury are discussed.
Liver Ultrasound Abnormalities in Alcohol Use Disorder
- MedicineEssentials of Abdominal Ultrasound
- 2019
The current knowledge about the use of liver ultrasound in patients with alcohol use disorder for the early detection of alcohol-related liver disease, as well as the potential use to detect other forms of liver disease are reviewed.
Managing medicines in alcohol-associated liver disease: a practical review
- MedicineAustralian prescriber
- 2021
People with alcohol-associated liver disease often take medicines to manage complications of liver disease and comorbidities, but patients may be at increased risk of drug-related harm with potentially inappropriate medicines.
Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis
- MedicineInternal medicine journal
- 2020
The rate of hospital admissions for cirrhosis increased 1.3‐fold during 2008‐2016 in Queensland and alcohol misuse was a contributing factor in 55% of admissions and patients had at least one comorbidity.
Management of alcohol-related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines.
- MedicineLiver international : official journal of the International Association for the Study of the Liver
- 2022
The French Association for the Study of the Liver wished to organise guidelines together with the French Alcohol Society in order to summarise the best evidence available about several key clinical points in ARLD.
Substance Use Disorders in Recently Hospitalized Patients With Cirrhosis
- MedicineJournal of addiction medicine
- 2020
Clinically-recognized SUD was common in recently hospitalized patients with cirrhosis and associated with at least 1 other hospitalization within a year and establishment of addiction treatment was documented in only a minority of patients.
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort)
- Medicine, BiologyLiver international : official journal of the International Association for the Study of the Liver
- 2021
Clinical and socio‐behavioural correlates of late presentation for care in HCV mono‐infected individuals are investigated to improve HCV strategies to optimize HCV cascade of care.
Long‐term prognosis of patients with metabolic (dysfunction)‐associated fatty liver disease by non‐invasive methods
- MedicineAlimentary pharmacology & therapeutics
- 2022
Non‐invasive assessment of fibrosis is predictive of the prognosis of non‐alcoholic and alcoholic fatty liver disease but this has not been demonstrated in metabolic (dysfunction)‐associated fatty…
References
SHOWING 1-10 OF 77 REFERENCES
Treatment of Alcohol Use Disorder in Patients with Alcoholic Liver Disease.
- Medicine, PsychologyThe American journal of medicine
- 2017
Treatment of alcohol use disorders in patients with alcoholic liver disease.
- MedicineJournal of hepatology
- 2016
The effect of caffeine and alcohol consumption on liver fibrosis – a study of 1045 Asian hepatitis B patients using transient elastography
- MedicineLiver international : official journal of the International Association for the Study of the Liver
- 2011
Background: Role of caffeine consumption in chronic hepatitis B virus (HBV)‐infected patients and the interaction with alcohol consumption is unclear.
Alcohol use in adults.
- Medicine, PsychologyThe New England journal of medicine
- 2013
Clinicians should routinely screen patients for risk drinking. Management strategies, including brief interventions, supervised withdrawal, specialty treatment, pharmacotherapy plus brief…
Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review
- MedicineHepatology
- 2017
A strong recommendation of benefit of moderate alcohol use in NAFLD cannot be made, and there remains a need for additional high‐quality longitudinal studies that evaluate both cardiovascular and liver outcomes amongNAFLD patients with moderate or lesser degrees of alcohol use.
Binge drinking and the risk of liver events: A population‐based cohort study
- MedicineLiver international : official journal of the International Association for the Study of the Liver
- 2017
It is investigated whether binge drinking increases the risk for liver disease above and beyond the risk due to average alcohol consumption.
Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?
- MedicineCurrent Hepatology Reports
- 2017
High alcohol consumption is associated with an increased risk of fibrosis progression and other adverse outcomes, while less is clear regarding low to moderate consumption in the setting of a concurrent liver disease.
Lifetime drinking history in patients with alcoholic liver disease and patients with alcohol use disorder without liver disease
- MedicineScandinavian journal of gastroenterology
- 2017
Females with ALD had significantly lower alcohol consumption than men with AlD despite similar duration in years of alcohol intake which supports the concept of female propensity of ALD.
A case-control study on alcohol consumption and the risk of chronic liver disease.
- MedicineRevue d'epidemiologie et de sante publique
- 1991
The results suggest that the evolution towards cirrhosis once a chronic liver damage has occurred is probably time-dependent, but not or minimally dependent on alcohol intake.